131 related articles for article (PubMed ID: 23652785)
1. A microfluidic origami chip for synthesis of functionalized polymeric nanoparticles.
Sun J; Xianyu Y; Li M; Liu W; Zhang L; Liu D; Liu C; Hu G; Jiang X
Nanoscale; 2013 Jun; 5(12):5262-5. PubMed ID: 23652785
[TBL] [Abstract][Full Text] [Related]
2. Polymeric-gold nanohybrids for combined imaging and cancer therapy.
Topete A; Alatorre-Meda M; Villar-Alvarez EM; Carregal-Romero S; Barbosa S; Parak WJ; Taboada P; Mosquera V
Adv Healthc Mater; 2014 Aug; 3(8):1309-25. PubMed ID: 24764284
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and characterization of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles as a sustained-release anticancer drug delivery system.
Amjadi I; Rabiee M; Hosseini MS; Mozafari M
Appl Biochem Biotechnol; 2012 Nov; 168(6):1434-47. PubMed ID: 22976852
[TBL] [Abstract][Full Text] [Related]
4. Ultrafine PEG-coated poly(lactic-co-glycolic acid) nanoparticles formulated by hydrophobic surfactant-assisted one-pot synthesis for biomedical applications.
Chu CH; Wang YC; Huang HY; Wu LC; Yang CS
Nanotechnology; 2011 May; 22(18):185601. PubMed ID: 21415469
[TBL] [Abstract][Full Text] [Related]
5. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
[TBL] [Abstract][Full Text] [Related]
6. A microfluidic tubing method and its application for controlled synthesis of polymeric nanoparticles.
Wang J; Chen W; Sun J; Liu C; Yin Q; Zhang L; Xianyu Y; Shi X; Hu G; Jiang X
Lab Chip; 2014 May; 14(10):1673-7. PubMed ID: 24675980
[TBL] [Abstract][Full Text] [Related]
7. Preparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticles.
Esmaeili F; Hosseini-Nasr M; Rad-Malekshahi M; Samadi N; Atyabi F; Dinarvand R
Nanomedicine; 2007 Jun; 3(2):161-7. PubMed ID: 17468055
[TBL] [Abstract][Full Text] [Related]
8. Augmented anticancer efficacy of doxorubicin-loaded polymeric nanoparticles after oral administration in a breast cancer induced animal model.
Jain AK; Swarnakar NK; Das M; Godugu C; Singh RP; Rao PR; Jain S
Mol Pharm; 2011 Aug; 8(4):1140-51. PubMed ID: 21557558
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization novel polymer-coated magnetic nanoparticles as carriers for doxorubicin.
Li F; Sun J; Zhu H; Wen X; Lin C; Shi D
Colloids Surf B Biointerfaces; 2011 Nov; 88(1):58-62. PubMed ID: 21764271
[TBL] [Abstract][Full Text] [Related]
10. Electrospray synthesis of monodisperse polymer particles in a broad (60 nm-2 μm) diameter range: guiding principles and formulation recipes.
Almería B; Gomez A
J Colloid Interface Sci; 2014 Mar; 417():121-30. PubMed ID: 24407667
[TBL] [Abstract][Full Text] [Related]
11. Multifunctional nanoparticles for combined doxorubicin and photothermal treatments.
Park H; Yang J; Lee J; Haam S; Choi IH; Yoo KH
ACS Nano; 2009 Oct; 3(10):2919-26. PubMed ID: 19772302
[TBL] [Abstract][Full Text] [Related]
12. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation.
Danhier F; Lecouturier N; Vroman B; Jérôme C; Marchand-Brynaert J; Feron O; Préat V
J Control Release; 2009 Jan; 133(1):11-7. PubMed ID: 18950666
[TBL] [Abstract][Full Text] [Related]
14. Design of a multifunctional PLGA nanoparticulate drug delivery system: evaluation of its physicochemical properties and anticancer activity to malignant cancer cells.
Wang Z; Chui WK; Ho PC
Pharm Res; 2009 May; 26(5):1162-71. PubMed ID: 19191012
[TBL] [Abstract][Full Text] [Related]
15. Folate receptor targeted 17-allylamino-17-demethoxygeldanamycin (17-AAG) loaded polymeric nanoparticles for breast cancer.
Saxena V; Naguib Y; Hussain MD
Colloids Surf B Biointerfaces; 2012 Jun; 94():274-80. PubMed ID: 22377218
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells.
Mo L; Hou L; Guo D; Xiao X; Mao P; Yang X
Int J Pharm; 2012 Oct; 436(1-2):815-24. PubMed ID: 22846410
[TBL] [Abstract][Full Text] [Related]
17. Application of rotatable central composite design in the preparation and optimization of poly(lactic-co-glycolic acid) nanoparticles for controlled delivery of paclitaxel.
Kollipara S; Bende G; Movva S; Saha R
Drug Dev Ind Pharm; 2010 Nov; 36(11):1377-87. PubMed ID: 20545520
[TBL] [Abstract][Full Text] [Related]
18. Etoposide encapsulation in surface-modified poly(lactide-co-glycolide) nanoparticles strongly enhances glioma antitumor efficiency.
Callewaert M; Dukic S; Van Gulick L; Vittier M; Gafa V; Andry MC; Molinari M; Roullin VG
J Biomed Mater Res A; 2013 May; 101(5):1319-27. PubMed ID: 23065812
[TBL] [Abstract][Full Text] [Related]
19. Engineering polymeric microparticles as theranostic carriers for selective delivery and cancer therapy.
Win KY; Ye E; Teng CP; Jiang S; Han MY
Adv Healthc Mater; 2013 Dec; 2(12):1571-5. PubMed ID: 23712912
[TBL] [Abstract][Full Text] [Related]
20. Development and optimization of N-Acetylcysteine-loaded poly (lactic-co-glycolic acid) nanoparticles by electrospray.
Karimi Zarchi AA; Abbasi S; Faramarzi MA; Gilani K; Ghazi-Khansari M; Amani A
Int J Biol Macromol; 2015 Jan; 72():764-70. PubMed ID: 25224287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
